|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300067555 |
|
最近更新日期: Date of Last Refreshed on: |
2023-09-12 21:26:27 |
|
注册时间: Date of Registration: |
2023-01-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
SEEK管芯复合视频喉镜对比纤支镜引导清醒气管插管对患者影响的多中心随机对照研究 |
|
Public title: |
Safe Easy Endotracheal Kit-flexible-guided endotracheal intubation reduces the stress response and postoperative airway complications under general anesthesia: a randomized controlled clinical study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
SEEK管芯复合视频喉镜对比纤支镜引导清醒气管插管对患者影响的多中心随机对照研究 |
|
Scientific title: |
Safe Easy Endotracheal Kit-flexible-guided endotracheal intubation reduces the stress response and postoperative airway complications under general anesthesia: a randomized controlled clinical study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
邹最 |
研究负责人: |
夏建华 |
|
Applicant: |
Zou Zui |
Study leader: |
Xia Jianhua |
|
申请注册联系人电话: Applicant telephone: |
+86 186 2112 2799 |
研究负责人电话:
Study leader's |
+86 136 0180 2789 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zouzui1980@163.com |
研究负责人电子邮件: Study leader's E-mail: |
jianhuaxia2000@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市黄浦区凤阳路415号 |
研究负责人通讯地址: |
上海市浦东新区川沙镇川环南路490号 |
|
Applicant address: |
415 Fengyang Road, Huangpu District, Shanghai |
Study leader's address: |
490 Chuanhuan Road South, Chuansha Town, Pudong New Area, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海长征医院 |
||
|
Applicant's institution: |
Shanghai Changzheng Hospital |
||
|
研究负责人所在单位: |
上海浦东新区人民医院 |
||
|
Affiliation of the Leader: |
Shanghai Pudong New Area People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2022)伦理第(K29)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海浦东新区人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Pudong New Area Renmin Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-12-06 00:00:00 | ||
|
伦理委员会联系人: |
周雪 |
||
|
Contact Name of the ethic committee: |
Zhou Xue |
||
|
伦理委员会联系地址: |
上海市浦东新区川沙镇川环南路490号3号楼2楼207室 |
||
|
Contact Address of the ethic committee: |
Room 207, 2nd Floor, Building 3, 490 Chuanhuan Road South, Chuansha Town, Pudong New Area, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 20509000 2048 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海浦东新区人民医院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Pudong New Area People's Hospital |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市浦东新区川沙镇川环南路490号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
490 Chuanhuan Road South, Chuansha Town, Pudong New Area, Shanghai |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
上海市优秀技术带头人 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Excellent Technology Leader in Shanghai |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
No |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
本研究将探究SEEK管芯在清醒气管患者中一次插管的成功率,并与纤支镜引导的清醒气管插管进行比较,探究两种插管方法的临床应用特点,为清醒气管插管患者的气道管理提供新的临床证据。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
This study will investigate the success rate of primary intubation with the SEEK core in awake tracheal patients and compare it with fibrinoscopy-guided awake tracheal intubation to investigate the clinical features of the two intubation methods and provide new clinical evidence for airway management in awake tracheal intubated patients. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
1. 大于18周岁小于80周岁患者; 2. 经术前气道评估需采用清醒气管插管患者; 3. 可置入可视喉镜患者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
1. Patients older than 18 years of age and younger than 80 years of age; 2. Patients requiring awake endotracheal intubation after preoperative airway assessment; 3. Visual laryngoscope can be inserted. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1. ASA分级IV或V级患者; 2. 牙齿松动严重; 3. 环甲膜穿刺禁忌患者; 4. 拒绝加入此项研究. |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with ASA classification IV or V; 2. Severely loosened teeth; 3. Patients for whom cricothyroid puncture is contraindicated; 4. Refusal to participate in the study. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-11-01 00:00:00至 To 2024-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-02-01 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
统计人员利用spss软件产生随机数,并将对应所组成的随机数字序列的所有随机数字指定分组为SEEK组和纤支镜组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The statisticians used spss software to generate random numbers and designated all random numbers corresponding to the composed random number sequence as group SEEK and fibrilloscope group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not shared |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据由三家医院按照制定的CRF表格进行采集,最后汇总到上海长征医院提取整理称电子数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The data is collected by the three hospitals according to a developed CRF form and finally aggregated to the Shanghai Long March Hospital for extraction and collation of the electronic data |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |